Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure TherapyCirculation (New York, N.Y.), 2015-06, Vol.131 (22), p.1981-1988 [Peer Reviewed Journal]2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.013777 ;PMID: 25948538Full text available |
|
2 |
Material Type: Article
|
Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and OpportunitiesJournal of the American College of Cardiology, 2014-09, Vol.64 (9), p.938-945 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2014.06.1167 ;PMID: 25169180 ;CODEN: JACCDIFull text available |
|
3 |
Material Type: Article
|
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololEuropean heart journal, 2016-06, Vol.37 (21), p.1671-1680 [Peer Reviewed Journal]The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology 2016 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw022 ;PMID: 26903532Full text available |
|
4 |
Material Type: Article
|
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and PreventionJournal of clinical oncology, 2018-07, Vol.36 (21), p.2135-2144 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.3920 ;PMID: 29874141Full text available |
|
5 |
Material Type: Article
|
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and managementCA: a cancer journal for clinicians, 2016-07, Vol.66 (4), p.309-325 [Peer Reviewed Journal]2016 American Cancer Society, Inc. ;Copyright Wiley Subscription Services, Inc. Jul-Aug 2016 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21341 ;PMID: 26919165 ;CODEN: CAMCAMFull text available |
|
6 |
Material Type: Article
|
Cardioprotective interventions for cancer patients receiving anthracyclinesCochrane database of systematic reviews, 2008-01 (2), p.CD003917 [Peer Reviewed Journal]EISSN: 1469-493X ;DOI: 10.1002/14651858.CD003917.pub3 ;PMID: 18425895Full text available |
|
7 |
Material Type: Article
|
Anthracycline Chemotherapy and CardiotoxicityCardiovascular drugs and therapy, 2017-02, Vol.31 (1), p.63-75 [Peer Reviewed Journal]The Author(s) 2017 ;Cardiovascular Drugs and Therapy is a copyright of Springer, 2017. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-016-6711-0 ;PMID: 28185035 ;CODEN: CDTHETFull text available |
|
8 |
Material Type: Article
|
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-AnalysisJournal of clinical oncology, 2016-09, Vol.34 (26), p.3157-3165 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;Distributed under a Creative Commons Attribution 4.0 International License ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.67.4846 ;PMID: 27458291Full text available |
|
9 |
Material Type: Article
|
Anthracyclines / Trastuzumab: new aspects of cardiotoxicity and molecular mechanismsTrends in pharmacological sciences (Regular ed.), 2015-06, Vol.36 (6), p.326-348 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0165-6147 ;EISSN: 1873-3735 ;DOI: 10.1016/j.tips.2015.03.005 ;PMID: 25895646Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupThe lancet oncology, 2015-03, Vol.16 (3), p.e123-e136 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 2015 ;2015 Elsevier Ltd. All rights reserved. Elsevier Ltd. All rights reserved. 2015 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70409-7 ;PMID: 25752563 ;CODEN: LANCAOFull text available |
|
11 |
Material Type: Article
|
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and preventionHeart (British Cardiac Society), 2018-06, Vol.104 (12), p.971-977 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2017-312103 ;PMID: 29217634Full text available |
|
12 |
Material Type: Article
|
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclinesBlood, 2017-04, Vol.129 (16), p.2257-2265 [Peer Reviewed Journal]2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-09-740332 ;PMID: 28143884Full text available |
|
13 |
Material Type: Article
|
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor StudyJournal of clinical oncology, 2019-05, Vol.37 (13), p.1090-1101 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.18.01764 ;PMID: 30860946Full text available |
|
14 |
Material Type: Article
|
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety studyAnnals of oncology, 2018-03, Vol.29 (3), p.646-653 [Peer Reviewed Journal]2017 THE AUTHORS ;The Author(s) 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx773 ;PMID: 29253081Full text available |
|
15 |
Material Type: Article
|
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting CellsImmunity (Cambridge, Mass.), 2013-04, Vol.38 (4), p.729-741 [Peer Reviewed Journal]2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Apr 18, 2013 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2013.03.003 ;PMID: 23562161Full text available |
|
16 |
Material Type: Article
|
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)Annals of oncology, 2013-09, Vol.24 (9), p.2278-2284 [Peer Reviewed Journal]2013 European Society for Medical Oncology ;2014 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdt182 ;PMID: 23704196Full text available |
|
17 |
Material Type: Article
|
Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline CardiotoxicityThe American journal of cardiology, 2013-12, Vol.112 (12), p.1980-1984 [Peer Reviewed Journal]Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 15, 2013 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2013.08.026 ;PMID: 24075281 ;CODEN: AJCDAGFull text available |
|
18 |
Material Type: Article
|
Adjuvant Trastuzumab in HER2-Positive Breast CancerThe New England journal of medicine, 2011-10, Vol.365 (14), p.1273-1283 [Peer Reviewed Journal]Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2011 Massachusetts Medical Society 2011 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0910383 ;PMID: 21991949 ;CODEN: NEJMAGFull text available |
|
19 |
Material Type: Article
|
Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT StudyCirculation (New York, N.Y.), 2023-02, Vol.147 (7), p.532-545 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.062814 ;PMID: 36342348Full text available |
|
20 |
Material Type: Article
|
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)Clinical cancer research, 2021-02, Vol.27 (4), p.975-982 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-3646 ;PMID: 33208340Full text available |